Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Current Assets (2023 - 2025)

Historic Current Assets for SANUWAVE Health (SNWV) over the last 10 years, with Q3 2025 value amounting to $22.6 million.

  • SANUWAVE Health's Current Assets rose 12852.38% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 million, marking a year-over-year increase of 12852.38%. This contributed to the annual value of $18.4 million for FY2024, which is 8803.15% up from last year.
  • As of Q3 2025, SANUWAVE Health's Current Assets stood at $22.6 million, which was up 12852.38% from $20.2 million recorded in Q2 2025.
  • SANUWAVE Health's 5-year Current Assets high stood at $22.6 million for Q3 2025, and its period low was $4.5 million during Q1 2023.
  • For the 3-year period, SANUWAVE Health's Current Assets averaged around $12.5 million, with its median value being $9.9 million (2024).
  • Data for SANUWAVE Health's Current Assets shows a peak YoY increase of 13978.3% (in 2024) and a maximum YoY decrease of 3394.64% (in 2024) over the last 5 years.
  • Over the past 3 years, SANUWAVE Health's Current Assets (Quarter) stood at $9.8 million in 2023, then soared by 88.03% to $18.4 million in 2024, then increased by 23.03% to $22.6 million in 2025.
  • Its Current Assets was $22.6 million in Q3 2025, compared to $20.2 million in Q2 2025 and $18.8 million in Q1 2025.